Low-dose strontium-90 irradiation is effective in preventing the recurrence of pterygia: a ten-year study

PLoS One. 2012;7(8):e43500. doi: 10.1371/journal.pone.0043500. Epub 2012 Aug 27.

Abstract

Background: To study the long-term effects of low-dosage strontium-90 (Sr90) irradiation on the recurrence of pterygium.

Methodology/principal findings: One hundred twenty eyes from 104 patients with primary or recurrent pterygia were treated with surgery followed by Sr90 irradiation. In brief, starting on the sixth day after surgery, patients were treated with irradiation three times every other day at a total combined dosage of 2000 cGy to 3000 cGy. Corneal topography was used to evaluate ocular surface regularity before and after treatment. Patient follow-up was performed 2 days, 5 days, 2 weeks, 1 month, 3 months, 1 year, 5 years, and 10 years after surgery. Recurrence of pterygium was not observed in any of the patients in this study. Obvious cataract progression was observed in 6 eyes, which may be due to aging. During follow-up studies, only one eye was reported with dryness and foreign-body sensation. Significant pterygium-induced astigmatism was observed in corneal topography, which decreased after surgery.

Conclusions/significance: Sr90 irradiation is effective in preventing the recurrence of primary and recurrent pterygia. We recommend delivering a total combined dosage of 2000 cGy to 3000 cGy of Sr90 irradiation administered in three batches every other day starting from the sixth day after surgery. Surgery is important in the rapid recovery of the cornea from pterygium-induced astigmatism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Astigmatism / etiology
  • Astigmatism / radiotherapy*
  • Cataract / complications
  • Cataract / pathology
  • Cornea / radiation effects
  • Corneal Topography
  • Humans
  • Middle Aged
  • Ophthalmology / methods
  • Pterygium / prevention & control*
  • Pterygium / radiotherapy*
  • Radiotherapy / methods
  • Recurrence
  • Strontium Radioisotopes / therapeutic use*
  • Time Factors
  • Treatment Outcome

Substances

  • Strontium Radioisotopes

Grants and funding

The Project was sponsored partly by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, the State Education Ministry (2005), the Natural Science Foundation of Shandong Province (ZR2012HM024), the Independent Innovation Foundation to Universities and Colleges by Jinan Science and Technology Bureau (201202036); and the Independent Innovation Foundation of Shandong University (2010JQ009). The funders were not involved in the study design, data collection and analysis, publishing decisions, or preparation of the manuscript.